At Vita10, we are committed to offering the highest quality IV treatments tailored to your unique needs
The multiple cardiometabolic benefits include improving glycemic control, lipid profiles, blood pressure, inflammation, and hepatic steatosis
Biological Activity Tesofensine exhibits potent appetite suppressant and weight-reducing effects in animal models and clinical studies
As a dual agonist for GIP and GLP-1 receptors, tirzepatide may provide superior weight reduction compared to selective GLP-1 agonists by targeting additional tissues and integrating signals from both receptor pathways in the brain.8,9 The efficacy of tirzepatide was evaluated in a phase 3 randomized withdrawal clinical trial (NCT04660643) with a 36-week, open-label tirzepatide lead-in period, followed by a 52-week, double-blind, placebo-controlled period, conducted at 70 sites in Argentina, Brazil, Taiwan, and the United States
Type 1 diabetes GLP-1 RA starts are currently off license and do blend better with individual consultations rather than a group setting at this time